Business Context and Reporting Period
This Form 8-K filing by Atlantic American Corporation covers events occurring between June 2, 2015, and June 5, 2015. The report addresses corporate governance changes, specifically the resignation of directors and a resulting deficiency in compliance with Nasdaq listing rules regarding the composition of the Audit Committee.
Financial Metrics
The filing text does not provide a clear value for revenue, profit, cash flow, margins, debt, or liquidity. This report focuses exclusively on corporate governance and regulatory compliance matters rather than financial performance.
Material Changes
- Director Resignations: Messrs. Edward E. Elson and Samuel E. Hudgins resigned from the Board effective May 18, 2015. Dr. William H. Whaley resigned effective June 3, 2015.
- Committee Appointment: Joseph M. Scheerer was appointed to the Audit Committee effective June 1, 2015, to fill a vacancy.
- Listing Deficiency: The Company notified Nasdaq of a failure to comply with Listing Rule 5605(c)(2), which requires at least three independent directors on the Audit Committee.
Outlook, Risks, and Management Commentary
Compliance Plan: The Company received a letter from Nasdaq on June 2, 2015, acknowledging the deficiency and granting a cure period until November 16, 2015, to regain compliance with Listing Rule 5605(c)(4).
Resolution Strategy: Management expects to appoint Keehln Wheeler, a nominee for election to the Board at the 2015 annual meeting, to the Audit Committee upon his election. This appointment is expected to restore full compliance with the listing rule.
Risks: The primary risk identified is the potential failure to regain compliance with Nasdaq listing standards by the November 16, 2015 deadline, which could impact the Company's continued listing status.
Key Facts for Investor Verification
- Verify the election results for Keehln Wheeler at the 2015 annual meeting of shareholders.
- Confirm the Company's appointment of Keehln Wheeler to the Audit Committee following his election.
- Monitor the Company's status regarding Nasdaq Listing Rule 5605(c)(2) compliance prior to the November 16, 2015 deadline.
- Review the composition of the Board of Directors to ensure the required number of independent directors is maintained.